70 A Randomized, Double-Blind, Placebo-Controlled Phase II Study (MOT114479) to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Orally Administered Camicinal, a Motilin Receptor Agonist, in Diabetics With GastroparesisMatthew E. Barton, George E. Dukes, Robert L. Dobbins et al.|Gastroenterology|2014Cited by 34
Tu1472 Multimodal Assessment of Gastric Residence Time, Whole Bowel Transit, Esophageal Function and Gastro-Esophageal Reflux Following Administration of the Motilin Agonist (GSK962040) in Healthy SubjectsAnthony Hobson, George E. Dukes, Odile Dewit et al.|Gastroenterology|2012Cited by 1